MEDIF(MEDIF)
MEDIF
No analyst ratings available
No analyst price targets available for MEDIF
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2026E | FY2027E |
|---|---|---|
| Revenue Avg | $28M | $32M |
| Low | $28M | $32M |
| High | $28M | $32M |
| EBITDA Avg | $-15M | $-17M |
| Low | $-15M | $-17M |
| High | $-15M | $-17M |
| EBIT Avg | $-16M | $-18M |
| Low | $-16M | $-18M |
| High | $-16M | $-18M |
| Net Income Avg | $-3M | $-2M |
| Low | $-3M | $-2M |
| High | $-3M | $-2M |
| EPS Avg | $-0.01 | $-0.00 |
| Low | $-0.01 | $-0.00 |
| High | $-0.01 | $-0.00 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 |
| Metric | Q3 2026 | Q4 2026 |
|---|---|---|
| Revenue Avg | $7M | $8M |
| Low | $7M | $8M |
| High | $7M | $8M |
| EBITDA Avg | $-4M | $-4M |
| Low | $-4M | $-4M |
| High | $-4M | $-4M |
| EBIT Avg | $-4M | $-5M |
| Low | $-4M | $-5M |
| High | $-4M | $-5M |
| Net Income Avg | $-493,614 | $-215,956 |
| Low | $-493,614 | $-215,956 |
| High | $-493,614 | $-215,956 |
| EPS Avg | $-0.00 | $-0.00 |
| Low | $-0.00 | $-0.00 |
| High | $-0.00 | $-0.00 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 |